Skip to main content
Long-term follow-up of patients with intermediate-risk neuroblastoma treated with response- and biology-based therapy: A report from the Children's Oncology Group study ANBL0531.
Treatment of relapsed/refractory severe aplastic anemia in children: Evidence-based recommendations.
Treatment of newly diagnosed severe aplastic anemia in children: Evidence-based recommendations.
Late cognitive and adaptive outcomes of patients with neuroblastoma-associated opsoclonus-myoclonus-ataxia-syndrome: A report from the Children's Oncology Group.
Desensitization using pegaspargase in the era of commercially available Erwinia: A single-institution report on efficacy, cost, and resource utilization.
Financial assistance and other financial coping strategies after a pediatric cancer diagnosis.
Pediatric arterial thrombosis: A single-institution cohort study of patient characteristics and thrombosis outcomes.
Norepinephrine transporter and vesicular monoamine transporter 2 tumor expression as a predictor of response to 131 I-MIBG in patients with relapsed/refractory neuroblastoma.
Busulfan and subsequent malignancy: An evidence-based risk assessment.
Racial and ethnic disparities in acuity of presentation among children with newly diagnosed acute leukemia.